7Baggers
 equillium cfo jason keyes sells $6,500 in stock  MSN Wed, 24 Sep 2025 13:50:11 GMT
 equillium (nasdaq:eq) shares down 2.8% - here's what happened  MarketBeat Wed, 24 Sep 2025 06:35:03 GMT
 equillium files prospectus supplement for up to $75 million stock offering  Investing.com Canada Sat, 20 Sep 2025 04:46:51 GMT
 equillium, inc. (nasdaq:eq) short interest down 37.5% in august  MarketBeat Fri, 19 Sep 2025 21:32:22 GMT
 Short Interest in Equillium, Inc. (NASDAQ:EQ) Decreases By 37.5%  MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
 Equillium Files Prospectus for $75 Million Stock Sale  TipRanks Fri, 19 Sep 2025 07:00:00 GMT
 Equillium files prospectus for $75 million share offering - SEC filing  MarketScreener Fri, 19 Sep 2025 07:00:00 GMT
 short interest in equillium, inc. (nasdaq:eq) drops by 37.5%  MarketBeat Fri, 19 Sep 2025 04:44:37 GMT
 equillium stock rallies 26% on itolizumab study data  MSN Wed, 17 Sep 2025 01:16:11 GMT
 short interest in equillium, inc. (nasdaq:eq) declines by 37.5%  MarketBeat Wed, 17 Sep 2025 00:55:35 GMT
 equillium, inc. (nasdaq:eq) short interest update  MarketBeat Wed, 17 Sep 2025 00:55:35 GMT
 Equillium stock rallies 26% on itolizumab study data  MSN Tue, 16 Sep 2025 07:36:35 GMT
 equillium, inc. (nasdaq:eq) short interest up 666.5% in august  MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
 equillium regains nasdaq compliance with bid price rule  MSN Sun, 07 Sep 2025 00:49:00 GMT
 equillium regains nasdaq compliance with bid price rule  MSN Sat, 06 Sep 2025 08:00:36 GMT
 Equillium Regains Nasdaq Compliance with Bid Price Rule  The Globe and Mail Fri, 05 Sep 2025 07:00:00 GMT
 Equillium Regains Nasdaq Compliance with Bid Price Rule  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 these were the 5 top-performing stocks in the nasdaq composite in august 2025  The Globe and Mail Wed, 03 Sep 2025 11:30:00 GMT
 equillium (nasdaq:eq) shares down 4.7% - should you sell?  MarketBeat Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 01:24:33  خودرو بانک Tue, 02 Sep 2025 21:55:52 GMT

Equillium, Inc
(NASDAQ:EQ) 

EQ stock logo

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is itolizumab, a clinical-stage monoclonal antibody that targets the novel immune ...

Founded: 2017
Full Time Employees: 26
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends